d-alpha tocopherol has been researched along with Chronic Hepatitis C in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (8.00) | 18.2507 |
| 2000's | 16 (64.00) | 29.6817 |
| 2010's | 6 (24.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borek, CG; Forrester, JE; Johnson, EJ; Knox, TA; Tang, AM; Wang, XD | 1 |
| Babany, G; Bonny, C; Chevallier, M; Cheveau, A; Desmorat, H; Melin, P; Pinta, A; Raabe, JJ; Rouanet, S; Sogni, P; Sturm, N; Zarski, JP | 1 |
| Bedossa, P | 1 |
| Hashimoto, Y; Kabeya, K; Kakizaki, S; Kaneko, M; Konaka, K; Mori, M; Nagamine, T; Sato, K; Shimojo, H; Sohara, N; Tago, Y; Takagi, H; Takahashi, H; Takayama, H; Tsukioka, G; Yamada, T | 1 |
| Bygum Krarup, H; Friis, H; Grønbaek, K; Poulsen, HE; Ring-Larsen, H; Sonne, J | 1 |
| Furutani, T; Hara, Y; Hino, K; Kitase, A; Murakami, Y; Nagai, A; Okita, K; Okita, M; Okuda, M; Ren, F; Yamaguchi, Y; Yamashita, S; Yutoku, K | 1 |
| Seen, S | 1 |
| Khan, DA; Mushtaq, S; Qureshi, AA; Qureshi, N; Xiong, M; Ye, SQ | 1 |
| Ji, HF; Shen, L; Sun, Y | 1 |
| Atsawarungruangkit, A; Bunchorntavakul, C; Wootthananont, T | 1 |
| Hasegawa, T; Sato, K; Yoneda, M | 1 |
| Ji, HF | 1 |
| Ascione, A; Caporaso, N; Carbone, A; Fogliano, V; Marmo, R; Morisco, F; Scarpati, S; Stingo, S; Vitaglione, P | 1 |
| Bajaj, JS; Daniel, J; Franco, J; Ho, S; Knox, JF; McKee, D; Peine, C; Saeian, K; Varma, RR | 1 |
| Bandara, P; Byth, K; Farrell, GC; George, J; Kench, J; Lux, O; McCaughan, G; Naidoo, D; Salonikas, C | 1 |
| D'Auria, M; de Sio, I; Di Leva, A; Federico, A; Loguercio, C; Niosi, M; Trappoliere, M; Tuccillo, C | 1 |
| Beucler, I; Bonnefont-Rousselot, D; Charlotte, F; Giral, P; Poynard, T; Ratziu, V | 1 |
| Hara, Y; Hino, K; Kawakami, T; Kitase, A; Murakami, Y; Nagai, A; Okita, K; Okita, M; Okuda, M | 1 |
| Friis, H; Groenbaek, K; Hansen, M; Krarup, HB; Ring-Larsen, H | 1 |
| Kakibuchi, N; Kawakami, T; Kawashima, A; Kita, K; Koyabu, T; Murakami, Y; Okita, M; Takaguchi, K | 1 |
| Kakibuchi, N; Kawakami, T; Kawashima, A; Kita, K; Koyabu, T; Murakami, Y; Okita, M; Takaguchi, K; Tsukamoto, I | 1 |
| Fischer, HP; Gerard, A; Look, MP; Rao, GS; Sauerbruch, T; Spengler, U; Sudhop, T | 1 |
| Airoldi, A; Bellobuono, A; Benetti, G; Bissoli, F; Cestari, C; Colombo, E; Del Poggio, P; Fracassetti, O; Idéo, G; Lazzaroni, S; Marelli, A; Mondazzi, L; Paris, B; Prada, A; Rainer, E; Roffi, L; Tempini, S | 1 |
| Chaplygina, G; Cherednichenko, T; Delenian, N; Kharlamova, F; Konev, V; Kovalev, O; Malinovskaya, V; Orlova, T; Uchaikin, V; Voronina, F | 1 |
| Aboutwerat, A; Burrows, PC; Jain, SK; McMahon, RF; Pemberton, PW; Smith, A; Warnes, TW | 1 |
3 review(s) available for d-alpha tocopherol and Chronic Hepatitis C
| Article | Year |
|---|---|
[Fibrosis in chronic hepatitis C infection: mechanisms and cofactors].
Topics: Adult; Age Factors; Aged; Alcoholism; alpha-Tocopherol; Antiviral Agents; Biopsy; Child; Cicatrix; Enzyme-Linked Immunosorbent Assay; Fatty Liver; Female; Hemochromatosis; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Immunohistochemistry; Inflammation; Lipid Peroxidation; Liver; Liver Cirrhosis; Male; Necrosis; Phenotype; Risk Factors; Sex Factors; Transforming Growth Factor beta | 2002 |
Chronic liver disease and oxidative stress - a narrative review.
Topics: Animals; Antioxidants; Antiviral Agents; Carcinoma, Hepatocellular; Chronic Disease; Dietary Supplements; Flavonoids; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Diseases; Liver Diseases, Alcoholic; Liver Neoplasms; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Reactive Oxygen Species; Vitamin E | 2021 |
Effect of vitamin E supplementation on aminotransferase levels in patients with NAFLD, NASH, and CHC: results from a meta-analysis.
Topics: Alanine Transaminase; Antioxidants; Aspartate Aminotransferases; Dietary Supplements; Hepatitis C, Chronic; Humans; Liver; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Vitamin E | 2014 |
11 trial(s) available for d-alpha tocopherol and Chronic Hepatitis C
| Article | Year |
|---|---|
Non-invasive assessment of liver fibrosis progression in hepatitis C patients retreated for 96 weeks with antiviral therapy: a randomized study.
Topics: Adult; alpha-Tocopherol; Antiviral Agents; Biomarkers; Biopsy; Disease Progression; Female; France; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Predictive Value of Tests; Recombinant Proteins; RNA, Viral; Time Factors; Treatment Outcome | 2010 |
Pilot clinical trial of the use of alpha-tocopherol for the prevention of hepatocellular carcinoma in patients with liver cirrhosis.
Topics: Alanine Transaminase; alpha-Fetoproteins; alpha-Tocopherol; Antioxidants; Carcinoma, Hepatocellular; Cholesterol; Female; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Pilot Projects; Platelet Count; Serum Albumin; Survival Rate | 2003 |
Alpha-tocopherol [corrected] and ascorbic acid attenuates the ribavirin [corrected] induced decrease of eicosapentaenoic acid in erythrocyte membrane in chronic hepatitis C patients.
Topics: alpha-Tocopherol; Ascorbic Acid; Drug Therapy, Combination; Eicosapentaenoic Acid; Erythrocyte Membrane; Female; Hepatitis C, Chronic; Humans; Liver Function Tests; Male; Middle Aged; Ribavirin; Treatment Outcome | 2006 |
Effects of vitamin E on chronic hepatitis C genotype 3: a randomized, double-blind, placebo-controlled study.
Topics: Adult; Alanine Transaminase; Antioxidants; Double-Blind Method; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Middle Aged; Oxidative Stress; Thailand; Vitamin E | 2014 |
High-dose vitamin E supplementation does not diminish ribavirin-associated haemolysis in hepatitis C treatment with combination standard alpha-interferon and ribavirin.
Topics: Adult; Antioxidants; Antiviral Agents; Drug Therapy, Combination; Female; Hemolysis; Hepatitis C, Chronic; Humans; Male; Quality of Life; Ribavirin; Vitamin E | 2004 |
[Effects of a new pharmacological complex (silybin + vitamin-E + phospholipids) on some markers of the metabolic syndrome and of liver fibrosis in patients with hepatic steatosis. Preliminary study].
Topics: Adult; Aged; Biomarkers; Drug Combinations; Fatty Liver; Female; Hepatitis C, Chronic; Humans; Insulin Resistance; Liver Cirrhosis; Male; Metabolic Syndrome; Middle Aged; Phospholipids; Pilot Projects; Silybin; Silymarin; Vitamin E | 2005 |
Vitamin E and C supplementation prevents decrease of eicosapentaenoic acid in mononuclear cells in chronic hepatitis C patients during combination therapy of interferon alpha-2b and ribavirin.
Topics: Alanine Transaminase; Antiviral Agents; Ascorbic Acid; Dietary Supplements; Drug Synergism; Drug Therapy, Combination; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Leukocytes, Mononuclear; Male; Middle Aged; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load; Vitamin E; Vitamins | 2006 |
The effect of antioxidant supplementation on hepatitis C viral load, transaminases and oxidative status: a randomized trial among chronic hepatitis C virus-infected patients.
Topics: Adult; Alanine Transaminase; Antioxidants; Ascorbic Acid; Biomarkers; Double-Blind Method; Female; Hepatitis C, Chronic; Humans; Male; Middle Aged; Selenium; Viral Load; Vitamin E | 2006 |
Zinc supplementation prevents the increase of transaminase in chronic hepatitis C patients during combination therapy with pegylated interferon alpha-2b and ribavirin.
Topics: Alanine Transaminase; Antiviral Agents; Ascorbic Acid; Carnosine; Dietary Supplements; Drug Therapy, Combination; Fatty Acids, Unsaturated; Female; Flow Cytometry; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Organometallic Compounds; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thiobarbituric Acid Reactive Substances; Time Factors; Transaminases; Treatment Outcome; Vitamin E; Vitamins; Zinc; Zinc Compounds | 2007 |
Interferon/antioxidant combination therapy for chronic hepatitis C--a controlled pilot trial.
Topics: Acetylcysteine; Adult; Antioxidants; Drug Therapy, Combination; Female; Glutathione; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Oxidative Stress; Peroxidase; Pilot Projects; Recombinant Proteins; RNA, Viral; Sodium Selenite; Thiobarbituric Acid Reactive Substances; Treatment Outcome; Vitamin E | 1999 |
Antioxidant drugs combined with alpha-interferon in chronic hepatitis C not responsive to alpha-interferon alone: a randomized, multicentre study.
Topics: Acetylcysteine; Alanine Transaminase; Antiviral Agents; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Prospective Studies; RNA, Viral; Treatment Failure; Vitamin E | 1999 |
11 other study(ies) available for d-alpha tocopherol and Chronic Hepatitis C
| Article | Year |
|---|---|
Factors associated with serum retinol, alpha-tocopherol, carotenoids, and selenium in Hispanics with problems of HIV, chronic hepatitis C, and drug use.
Topics: Adult; alpha-Tocopherol; Carotenoids; Cohort Studies; Female; Hepatitis C, Chronic; Hispanic or Latino; HIV Infections; Humans; Male; Middle Aged; Selenium; Substance-Related Disorders; United States; Vitamin A | 2009 |
Viral load is a negative predictor of antioxidant levels in hepatitis C patients.
Topics: Adult; alpha-Tocopherol; Antioxidants; Ascorbic Acid; beta Carotene; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Middle Aged; Oxidative Stress; Viral Load | 2005 |
δ-Tocotrienol feeding modulates gene expression of EIF2, mTOR, protein ubiquitination through multiple-signaling pathways in chronic hepatitis C patients.
Topics: Eukaryotic Initiation Factor-2; Gene Expression Profiling; Gene Expression Regulation; Hepatitis C, Chronic; Humans; Signal Transduction; TOR Serine-Threonine Kinases; Ubiquitination; Vitamin E | 2018 |
Vitamin E therapy for NAFLD/NASH.
Topics: Alanine Transaminase; Antioxidants; Aspartate Aminotransferases; Dietary Supplements; Hepatitis C, Chronic; Humans; Non-alcoholic Fatty Liver Disease; Vitamin E | 2015 |
Vitamin E therapy on aminotransferase levels in NAFLD/NASH patients.
Topics: Alanine Transaminase; Antioxidants; Aspartate Aminotransferases; Dietary Supplements; Hepatitis C, Chronic; Humans; Non-alcoholic Fatty Liver Disease; Vitamin E | 2015 |
Tomato-based functional food as interferon adjuvant in HCV eradication therapy.
Topics: Antioxidants; Antiviral Agents; Biological Availability; Carotenoids; Drug Therapy, Combination; Female; Flavonoids; Hepatitis C, Chronic; Humans; Interferons; Male; Oxidative Stress; Ribavirin; Treatment Outcome; Vitamin E | 2004 |
Antioxidant levels in peripheral blood, disease activity and fibrotic stage in chronic hepatitis C.
Topics: Adolescent; Adult; Aged; Antioxidants; Ascorbic Acid; Biomarkers; Biopsy; Cohort Studies; Dietary Supplements; Female; Glutathione; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis; Severity of Illness Index; Viral Load; Vitamin E | 2005 |
Blood oxidative stress markers are unreliable markers of hepatic steatosis.
Topics: Adult; Biomarkers; Cholesterol; Fatty Liver; Female; Glutathione Peroxidase; Hepatitis C, Chronic; Humans; Male; Middle Aged; Oxidative Stress; Selenium; Superoxide Dismutase; Vitamin E | 2006 |
Eicosapentaenoic acid supplementation for chronic hepatitis C patients during combination therapy of pegylated interferon alpha-2b and ribavirin.
Topics: Alanine Transaminase; Antiviral Agents; Ascorbic Acid; Dietary Supplements; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Vitamin E | 2008 |
Use of recombinant alpha-2b-interferon in combination with antioxidants in the form of rectal suppositories (viferon) in children with chronic hepatitides B and C.
Topics: Adolescent; Antioxidants; Antiviral Agents; Ascorbic Acid; B-Lymphocytes; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Infant; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Suppositories; T-Lymphocytes; Treatment Outcome; Vitamin E | 2000 |
Oxidative stress in chronic hepatitis C: not just a feature of late stage disease.
Topics: Adult; Aged; Antioxidants; Ascorbic Acid; Dinoprost; F2-Isoprostanes; Female; Glutathione; Hepatitis C, Chronic; Humans; Lipid Peroxidation; Liver Cirrhosis; Male; Middle Aged; Oxidative Stress; Selenium; Vitamin A; Vitamin E | 2002 |